Our primary objectives are to investigate the causal relationship between obesity and IVDD and to identify the role of FABP4 in obesity‐induced IVDD and the molecular mechanisms by which FABP4 mediates ECM imbalance and angiogenesis. Here, FABP4 is linked to obesity disorder.